drugset / Trial / NCT02731378

Erythropoietin and Iron Supplementation for Patients With Chemotherapy-induced Anaemia

NCT02731378

Phase 4 Unknown 603 enrolled Shanghai East Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

A multicentre, randomized, open-label, parallel-group, active controlled non-inferiority study

Timeline

Start
2016-12
Primary completion
2019-04
Completion
2019-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Iron dextran Unknown 100 mg Intravenous
Subject Iron dextran Unknown 200 mg Intravenous

Indications